JP Morgan Chase’s Boston Scientific BSX Stock Holding History

JP Morgan Chase’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.04B	Sell	23,907,838 -9,442,319	-28%	-$513M	0.06%	265
2026 Q1	$2.1B	Buy	33,350,157 +7,977,271	+31%	+$638M	0.13%	152
2025 Q4	$2.42B	Sell	25,372,886 -2,956,323	-10%	-$290M	0.15%	147
2025 Q3	$2.77B	Buy	28,329,209 +2,669,487	+10%	+$276M	0.17%	127
2025 Q2	$2.76B	Sell	25,659,722 -5,862,792	-19%	-$593M	0.18%	119
2025 Q1	$3.18B	Buy	31,522,514 +5,278,861	+20%	+$532M	0.23%	99
2024 Q4	$2.34B	Buy	26,243,653 +204,261	+0.8%	+$18M	0.17%	132
2024 Q3	$2.18B	Sell	26,039,392 -524,283	-2%	-$41.3M	0.17%	132
2024 Q2	$2.05B	Sell	26,563,675 -4,915,959	-16%	-$360M	0.17%	123
2024 Q1	$2.16B	Buy	31,479,634 +2,845,922	+10%	+$183M	0.18%	119
2023 Q4	$1.66B	Buy	28,633,712 +4,529,740	+19%	+$242M	0.16%	136
2023 Q3	$1.27B	Buy	24,103,972 +940,531	+4%	+$49.3M	0.14%	151
2023 Q2	$1.25B	Sell	23,163,441 -10,514,440	-31%	-$549M	0.14%	163
2023 Q1	$1.68B	Sell	33,677,881 -13,747,665	-29%	-$648M	0.21%	115
2022 Q4	$2.19B	Sell	47,425,546 -3,214,061	-6%	-$139M	0.29%	90
2022 Q3	$1.96B	Sell	50,639,607 -870,168	-2%	-$34.9M	0.28%	84
2022 Q2	$1.92B	Buy	51,509,775 +3,738,113	+8%	+$152M	0.27%	88
2022 Q1	$2.12B	Buy	47,771,662 +956,611	+2%	+$41.5M	0.25%	88
2021 Q4	$1.99B	Buy	46,815,051 +9,427,386	+25%	+$396M	0.23%	94
2021 Q3	$1.62B	Sell	37,387,665 -2,181,758	-6%	-$96.5M	0.2%	117
2021 Q2	$1.69B	Sell	39,569,423 -800,780	-2%	-$33.7M	0.2%	114
2021 Q1	$1.56B	Buy	40,370,203 +677,071	+2%	+$25.6M	0.21%	110
2020 Q4	$1.43B	Sell	39,693,132 -1,862,121	-4%	-$67.1M	0.21%	114
2020 Q3	$1.57B	Buy	41,555,253 +2,029,505	+5%	+$78.2M	0.26%	78
2020 Q2	$1.39B	Buy	39,525,748 +2,051,581	+5%	+$73.9M	0.27%	77
2020 Q1	$1.22B	Sell	37,474,167 -2,581,837	-6%	-$101M	0.29%	79
2019 Q4	$1.81B	Sell	40,056,004 -2,254,655	-5%	-$94.3M	0.34%	57
2019 Q3	$1.72B	Sell	42,310,659 -3,810,662	-8%	-$161M	0.34%	57
2019 Q2	$1.93B	Sell	46,121,321 -2,387,930	-5%	-$91.8M	0.38%	47
2019 Q1	$1.86B	Sell	48,509,251 -1,696,203	-3%	-$64.8M	0.38%	47
2018 Q4	$1.77B	Buy	50,205,454 +3,147,198	+7%	+$114M	0.41%	44
2018 Q3	$1.81B	Buy	47,058,256 +2,701,658	+6%	+$94.4M	0.35%	51
2018 Q2	$1.45B	Buy	44,356,598 +2,703,163	+6%	+$81.5M	0.3%	64
2018 Q1	$1.14B	Sell	41,653,435 -5,356,712	-11%	-$146M	0.24%	82
2017 Q4	$1.17B	Sell	47,010,147 -5,323,817	-10%	-$147M	0.25%	76
2017 Q3	$1.5B	Sell	52,333,964 -2,068,519	-4%	-$57.1M	0.33%	55
2017 Q2	$1.51B	Buy	54,402,483 +3,083,119	+6%	+$81.8M	0.34%	54
2017 Q1	$1.28B	Sell	51,319,364 -260,749	-0.5%	-$6.34M	0.29%	67
2016 Q4	$1.12B	Buy	51,580,113 +5,503,747	+12%	+$120M	0.27%	84
2016 Q3	$1.1B	Buy	46,076,366 +202,502	+0.4%	+$4.83M	0.27%	80
2016 Q2	$1.07B	Buy	45,873,864 +24,672,937	+116%	+$534M	0.27%	85
2016 Q1	$399M	Sell	21,200,927 -8,082,934	-28%	-$142M	0.1%	228
2015 Q4	$540M	Sell	29,283,861 -7,503,028	-20%	-$134M	0.14%	179
2015 Q3	$604M	Sell	36,786,889 -17,167,838	-32%	-$293M	0.16%	153
2015 Q2	$955M	Sell	53,954,727 -9,670,972	-15%	-$173M	0.23%	87
2015 Q1	$1.13B	Sell	63,625,699 -13,572,081	-18%	-$214M	0.26%	79
2014 Q4	$1.02B	Sell	77,197,780 -4,906,280	-6%	-$62.7M	0.23%	89
2014 Q3	$970M	Buy	82,104,060 +19,518,470	+31%	+$246M	0.23%	89
2014 Q2	$799M	Buy	62,585,590 +50,554,706	+420%	+$657M	0.2%	104
2014 Q1	$163M	Buy	12,030,884 +6,392,490	+113%	+$83.9M	0.04%	421
2013 Q4	$67.8M	Sell	5,638,394 -602,683	-10%	-$7.12M	0.02%	672
2013 Q3	$73.3M	Buy	6,241,077 +2,030,029	+48%	+$22M	0.02%	647
2013 Q2	$39M	Buy	+4,211,048	New	+$35.7M	0.01%	852

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

JP Morgan Chase's BSX Position: Q2 2026 in Review

JP Morgan Chase reduced its Boston Scientific (BSX) stake by 28% in Q2 2026, selling an estimated $513M and leaving 23,907,838 shares worth $1.04B. The position accounts for 0.06% of the portfolio, ranked #265.

JP Morgan Chase first reported a position in BSX in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.18B in Q1 2025. 1,050 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

JP Morgan Chase held 23,907,838 shares of Boston Scientific worth $1.04B as of Q2 2026.
JP Morgan Chase sold 9,442,319 Boston Scientific shares in Q2 2026, an estimated $513M.
Boston Scientific made up 0.06% of JP Morgan Chase's portfolio in Q2 2026, its #265 holding.
JP Morgan Chase first reported a position in Boston Scientific in Q2 2013 and has held it in 53 quarters since.
JP Morgan Chase's Boston Scientific position peaked at $3.18B in Q1 2025.
1,050 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.